Small-caps have outrun their mid- and large-cap peers in the month (since March 25) that the country has been under lockdown, triggered by the coronavirus disease (Covid-19) pandemic.
The S&P BSE SmallCap index recovered 25.1 per cent, compared with a 24.3 per cent rise in the S&P BSE Sensex, and 22.1 per cent gain in the S&P BSE MidCap index from their respective 52-week lows seen on March 24. The run-up has been on account of a rally in stocks of pharmaceutical, fertiliser, chemicals and auto ancillary stocks.
